ArticleInternational journal of cancer2016

Development of ZMYM2-FGFR1 driven AML in human CD34+ cells in immunocompromised mice.

Mingqiang Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.